Twinrix vaccine syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FDA4L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,470
Award facts
- Contract value 100% obligated
- $33,470.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $33,470.40 to AmerSourceBergen Drug Corp for the supply of Twinrix vaccine syringes on January 20, 2026, with an ultimate completion date of January 21, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company being Cencora, Inc. (doing business as AmerSourceBergen). The contract is executed under Cencora's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which serves as a global pharmaceutical support vehicle enabling the supply of a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
This delivery order represents a routine pharmaceutical procurement supporting the Defense Logistics Agency's medical supply chain operations. The Twinrix vaccine—a combination immunization against hepatitis A and B—is a standard medical commodity required by military treatment facilities and related federal healthcare systems. As a child contract under the larger DLA Troop Support Medical IDC, this award leverages AmerSourceBergen's established capability and capacity as a critical pharmaceutical distributor to the federal government. The company's extensive portfolio of competitively awarded federal contracts demonstrates its ability to fulfill diverse medical supply needs across multiple therapeutic domains for defense and civilian government agencies.
Quick answers
Who was awarded contract SPE2DR26FDA4L?
SPE2DR26FDA4L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FDA4L worth?
The government has obligated $33,470 on SPE2DR26FDA4L.
Is contract SPE2DR26FDA4L an order under another contract?
Yes. SPE2DR26FDA4L is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDA4L competed?
The extent of competition for SPE2DR26FDA4L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award